associated with a higher prevalence of atherosclerosis. We evaluated the relationship of LVH to smoking.
P-146 LEFT VENTRICULAR REMODELING, CAROTID INTIMA-MEDIA THICKNESS AND ENDOTHELIAL FUCTION IN UNTREATED HYPERTENSIVE PATIENTS
The purpose of the study was to estimate the prevalence and determinants of distinct patterns of left ventricular remodeling in hypertensive patients in St.Petersburg population and their relation to intima-media thickness (IMT) and endothelial function of the arteries.
A cross-sectional study in a population-based sample of 734 essential hypertensives from the primary care clinic was undertaken. Echocardiography was performed and analyzed by trained observers. The left ventricular posterior wall thickness (PW), interventricular septum (IVS) and left ventricular mass index (LVMI) were measured. High resolution B-mode ultrasound was used to determine IMT (the mean of 12 measurements), Vascular ultrasound was performed to measure the brachial artery diameter during reactive hyperaemia test and analysis of endothelium-dependent vasodilatation.
Left ventricular hypertrophy (LVH) was more prevalent in women than in men (67,4 vs 57,4%, 2 ϭ 8,8, pϽ0,05). Normal geometry was diagnosed in 217 patients (30%), concentric LVH in 238 (32%), eccentric one in 230 (31%) and concentric remodeling in 49 (7%).The proportion of concentric hypertrophy increased from mild to severe hypertension (18 to 66%). Sex, obesity stage and type, and hypertension level and duration contributed to LVH level and remodeling pattern. Parameters of vascular ultrasound differed significantly in different remodeling patterns. IMT thickness was higher in concentric LVH group (1,03Ϯ0,21 comared to 0,79Ϯ0,16 in normal geometry pattern, as well as to 0,93Ϯ0,08 in eccentric LVH, pϽ0.01). The same tendency was observed concerning endothelial fucntion. Endothelial-dependent vasodilatation (EDVD) was significantly reduced in concentric LVH (4,1Ϯ0,6%) compared to eccentric LVH (5,0Ϯ0,9) (pϽ0.01).
Thus, the pattern of LV geometry in hypertension seems to be determined by the level of hypertension as well as gender and obesity type.
Vascular remodeling and endothelial dysfunction seems to be associated with LV remodeling pattern, being more severe in concentric LVH. Chronic congestive heart failure is connected with increased sympathetic nervous system activity and decreased parasympathetic nervous activity -that contributes to the progression of disease and increase of mortality. It is very important to search new drugs for improvement of sympathoparasympathetic activity in heart failure. Mildronate has been synthesised at Latvian Institute of Organic Synthesis. It is metabolic drug that modulates individual stages of energy metabolism in myocardium. Mildronate belongs to the group of cytoprotectors / antihypoxants and ensures cellular protection and energy supply in conditions of ischemia and high stress.
Objective: To investigate the effect of Mildronate upon carotid baroreflex function in heart failure.
Design and Methods: 60 pts. with stable heart failure(no changes in medical therapy within the last 2 months, aged 51-76 yr., II-III class (according to NYHA) were randomly assigned in double-blind fashion to receive either 1000 mg of Mildronate or placebo. At the beginning of study and after 12 weeks of treatment beat-to-beat heart rate and finger mean arterial pressure were monitored non-invasively. Bradycardic and hypotensive reaction to carotid baroreceptors activation were studied, applying neck suction (-60 mmHg for 5s).
Results: Mildronate (dose 1000 mg/day) in addition to standard therapy is associated with no significant decrease of mean arterial pressure, diastolic blood pressure and heart rate. Systolic blood pressure (pϽ0.05) decreases and bradycardic and hypotensive reactions to carotid baroreceptors activation increase (pϽ0.01) significantly after Mildronate therapy.
Conclusions: 12-week treatment period with Mildronate significantly improves sympatho-parasympathetic balance in patients with stable heart failure. 
Background:
We have previously shown that mice with homozygous deletion of the pro-atrial natriuretic peptide (ANP, NppaϪ/Ϫ) gene exhibit left ventricular (LV) hypertrophy at baseline and exaggerated hypertrophy after pressure overload induced by transverse aortic constriction (TAC). NppaϪ/Ϫ mice have increased expression of extracellular matrix molecules, i.e. metalloproteinase-2 and tissue inhibitor of metalloproteinase-3 and cardiac remodeling after TAC.
Hypothesis: A single copy of the pro-ANP gene (Nppaϩ/Ϫ) will not be adequate to protect heterozygous mice against exaggerated LV hy-86A AJH-May 2004 -VOL. 17, NO. 5 , PART 2 POSTERS: Heart Failure/Hypertrophy
